CANCER CELLS PRESENT

This adverse event was reported 43 times

These drugs are most commonly taken by patients reporting CANCER CELLS PRESENT:

# Drug Count
0 UPADACITINIB 7
1 ACETAMINOPHEN 3
2 DURVALUMAB 3
3 ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE 2
4 ADALIMUMAB 2
5 FINASTERIDE 2
6 IBRUTINIB 2
7 LENALIDOMIDE 2
8 VENETOCLAX 2
9 VITAMIN C 2
See all common drugs associated with CANCER CELLS PRESENT

CANCER CELLS PRESENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE 1 0.0009
1 PYRIDOXINE HYDROCHLORIDE 1 0.0004
2 PRASTERONE 1 0.0004
3 ABROCITINIB 1 0.0003
4 IVERMECTIN 1 0.0002
5 DURVALUMAB 3 0.0001
6 ADO-TRASTUZUMAB EMTANSINE 1 0.0001
7 LUBIPROSTONE 1 0.0001
8 MISOPROSTOL 1 0.0001
9 CLADRIBINE 1 0.0001
See all drugs enriched for association with CANCER CELLS PRESENT

CANCER CELLS PRESENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antiparasitic [EPC] 1 0.0002
1 Pediculicide [EPC] 1 0.0002
2 Programmed Death Ligand-1 Blocker [EPC] 3 0.0001
3 Chloride Channel Activator [EPC] 1 0.0001
4 GLP-2 Analog [EPC] 1 0.0001
5 Radioligand Therapeutic Agent [EPC] 1 0.0001
6 Prostaglandin E1 Analog [EPC] 1 0.0001
7 Janus Kinase Inhibitor [EPC] 8 0.0000
8 Human Immunoglobulin G [EPC] 1 0.0000
9 Bile Acid [EPC] 1 0.0000
See all drug classes enriched for association with CANCER CELLS PRESENT